All
Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates
Herrera C, Armanasco, N, García-Pérez J, Ziprin P, Olejniczak N, Alcamí J, Nuttall J, Shattock RJ. AIDS. 30, no. 7 (24 Apr 2016):1015-1025. More »
Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues
Fletcher P, Herrera C, Armanasco N, Nuttall J, Shattock RJ. AIDS Research and Human Retroviruses. 32, no. 4(Mar 2016): 334-8. More »
Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device
Murphy DJ, Boyd P, McCoy CF, Kumar S, Holt JDS, Blanda W, Brimer AN, Malcolm RK. Journal of Controlled Release. 226 (28 Mar 2016): 138-147. More »
Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
Nel A, Bekker LG, Bukusi E, Hellstrӧm, Kotze P, Louw C, Martinson F, Masenga G, Montgomery E, Ndaba N, van der Straten A, van Niekerk N, Woodsong C. PLOS ONE. 10 Mar 2016, doi: 10.1371/journal.pone.... More »
A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of a novel dapivirine vaginal film
Bunge KE, Dezzutti CS, Rohan LC, Hendrix CW, Marzinke MA, Richardson-Harman N, Moncla BJ, Devlin B, Meyn LA, Spiegel HML, Hillier SL. Journal of Acquired Immune Deficiency Syndromes. Epub 2015 Nov 11. More »